Please click the button below to report on a patient with cancer and COVID-19. See below for eligibility.
Please click the button below to report on a patient with cancer and COVID-19. See below for eligibility.
We are collecting reports on adult patients (18 and older) with a current or historical invasive solid or hematologic malignancy who have been diagnosed with COVID-19, with or without laboratory confirmation of SARS-CoV-2 infection. Reporting is anonymous and all reported data must be de-identified. This study is registered with ClinicalTrials.gov, NCT04354701, and is ongoing.
Healthcare providers (or their proxies) from the United States, the European Union (EU), Argentina, Canada, Mexico, and the United Kingdom (UK) are eligible to report cases. If you don't see your country or region on this list, keep checking back - we are actively working to expand internationally.
We are a consortium of over 120 cancer centers and other organizations who have come together to collect data about patients with cancer who have been diagnosed with COVID-19.
The driving goal of the CCC19 consortium is to collect and disseminate prospective, granular, uniformly organized information on people with cancer who are diagnosed with COVID-19 – at scale and as rapidly as possible.
List of Participating Institutions
(*) NCI-designated Comprehensive Cancer Center
(**) NCI-designated Cancer Center
Founding Institutions
Additional Institutions
Please send us a message if you have a question or would like to participate in the COVID-19 and Cancer Consortium.
